tacrine has been researched along with 9-(3-(2-nitro-1-imidazolyl)propylamino)-1,2,3,4-tetrahydroacridine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloomer, WD; Doddi, M; Papadopoulou, MV; Rosenzweig, HS | 1 |
| Bloomer, WD; Ji, M; Papadopoulou, MV | 1 |
| Bloomer, WD; Ji, M; Khan, SH; Papadopoulou, MV | 1 |
3 other study(ies) available for tacrine and 9-(3-(2-nitro-1-imidazolyl)propylamino)-1,2,3,4-tetrahydroacridine
| Article | Year |
|---|---|
9-[3-(2-Nitro-1-imidazolyl)propylamino]-1,2,3,4-tetrahydroacridine hydrochloride. A novel DNA-affinic hypoxic cell cytotoxin and radiosensitizer. Comparison with NLA-1.
Topics: Aerobiosis; Aminoacridines; Animals; Cell Hypoxia; Cells, Cultured; Cricetinae; Cricetulus; DNA; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Superhelical; Intercalating Agents; Lung; Nitroimidazoles; Radiation-Sensitizing Agents; Tacrine | 1994 |
THNLA-1 as radio/chemosensitiser of EMT-6 tumours in mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Synergism; Etanidazole; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Radiation-Sensitizing Agents; Tacrine | 1996 |
Mechanisms involved in the potentiation of melphalan by the bioreductive compound THNLA-1 in vitro.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Buthionine Sulfoximine; Cell Cycle; Cell Hypoxia; Cell Line; Comet Assay; Cricetinae; Cricetulus; DNA; DNA Damage; DNA Repair; Drug Synergism; Glutathione; Melphalan; Protein Biosynthesis; Proteins; Radiation-Sensitizing Agents; RNA; Tacrine | 1999 |